Evidence map›Paper›PMID 27303601›Full record

ArticleBasic and clinical neuroscience2016

Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement.

Mahdi Goudarzvand, Samira Choopani, Alireza Shams, Mohammad Javan, Zohreh Khodaii, Farhad Ghamsari, Naser Naghdi, Abbas Piryaei, Abbas Haghparast

Open access · greenAbstract read
In one paragraph

Article in Basic and clinical neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Mahdi GoudarzvandDepartment of Physiology and Pharmacology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Samira ChoopaniDepartment of Physiology and Pharmacology, Pasteur Institute, Tehran, Iran.
Alireza ShamsDepartment of Anatomy, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Mohammad JavanDepartment of Physiology, Faculty of Medicine, Tarbiat Modares University, Tehran, Iran.
Zohreh KhodaiiDepartment of Nutrition, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Farhad GhamsariDepartment of Internal Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Naser NaghdiDepartment of Physiology and Pharmacology, Pasteur Institute, Tehran, Iran.
Abbas PiryaeiDepartment of Anatomy, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abbas HaghparastDepartment of Physiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Jahrom University of Medical Sciences · IRPasteur Institute of Iran · IRShahid Beheshti University of Medical Sciences · IRAlborz University of Medical SciencesTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMemory and cognitive impairments are some of devastating outcomes of Multiple Sclerosis (MS) plaques in hippocampus, the gray matter part of the brain. The present study aimed to evaluate the intrahippocampal injection of Ethidium Bromide (EB) as a simple and focal model to assess cognition and gray matter demyelination.

methodsThirty Wistar rats were divided into three groups: control group, which received saline, as solvent of EB, into the hippocampus; and two experimental groups, which received 3 μL of EB into the hippocampus, and then, were evaluated 7 and 28 days after EB injection (n=10 in each group), using a 5-day protocol of Morris Water Maze (MWM) task as well as Transmission Electron Microscopy (TEM) assay.

resultsSeven days after EB injection, the behavioral study revealed a significance increase in travelled distance for platform finding in the experimental group compared to the control group. In addition, the nucleus of oligodendrocyte showed the typical clumped chromatin, probably attributed to apoptosis, and the myelin sheaths of some axons were unwrapped and disintegrated. Twenty-eight days after EB injection, the traveled distance and the time spent in target quadrant significantly decreased and increased, respectively in experimental groups compared to the control group. Also, TEM micrographs revealed a thin layer of remyelination around the axons in 28 days lesion group. DISCUSSION: While intracerebral or intraventricular injection of EB is disseminated in different parts of the brain and can affect the other motor and sensory systems, this model is confined locally and facilitates behavioral study. Also, this project could show improvement of memory function subsequent to the physiological repair of the gray matter of the hippocampus.

Indexed as

BehaviorEthidium bromideHippocampusRatRemyelination

Identifiers

PMID27303601
PMCPMC4892333
OpenAlexW2395031718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.